By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Regen BioPharma  

4700 Spring Street
Suite 304
La Mesa  California  91942  U.S.A.
Phone: 619-702-1404 Fax: 619-330-2328


Company News
Regen BioPharma Engages Charles River Laboratories To Initiate FDA-Requested Study To Support Initiation Of HemaXellerate Clinical Trial 4/23/2015 11:49:50 AM
Regen BioPharma Recruits Renowned Cancer Stem Cell Experts To Scientific Advisory Board 4/17/2015 11:02:47 AM
Regen BioPharma Narrows Selection Of CRO Candidates For HemaXellerate GLP Safety Studies Requested By The FDA 4/14/2015 12:56:57 PM
Regen BioPharma Announces Small Molecule Drug Discovery Milestones At American Association for Cancer Research's 2015 Annual Meeting 4/9/2015 10:05:32 AM
Regen BioPharma To Present Multiple Presentations At The 13th International Symposium On Myelodysplastic Syndromes 4/7/2015 12:28:54 PM
Regen BioPharma Expands Its Differentiation Therapy of Cancer Stem Cells Platform With Filing Of Patent Applications On Silencing Of NR2F2 4/7/2015 10:17:10 AM
Regen BioPharma CEO Discusses Recent Financings, New Laboratory Facilities And Preferred Stock Dividend 4/3/2015 9:39:40 AM
Regen BioPharma Announces Presentation Of DiffronC At Cold Spring Harbor Conference On RNA & Oligonucleotide Therapeutics 4/3/2015 9:35:25 AM
Regen BioPharma Expands Research Capacity With New Laboratory Facilities 3/24/2015 11:11:40 AM
Regen BioPharma Receives Green Light From FDA To Proceed With GLP Safety Study In Support Of Its Hemaxellerate Investigational New Drug Application 3/18/2015 1:09:53 PM